Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > PTCT PTC Therapeutics > Detailed Quotes

PTCT PTC Therapeutics

Watchlist
41.120
-0.940-2.23%
Close  12/05 16:00 ET
41.1200.0000.00%
Post Mkt Price 12/05 16:46 ET
High
42.335
Open
42.090
Turnover
20.83M
Low
40.800
Pre Close
42.060
Volume
506.03K
Market Cap
2.96B
P/E(TTM)
Loss
52wk High
55.580
Shares
71.88M
P/E(Static)
Loss
52wk Low
25.010
Float Cap
2.65B
Bid/Ask %
33.33%
Historical High
78.720
Shs Float
64.45M
Volume Ratio
1.01
Historical Low
4.030
Dividend TTM
--
Div Yield TTM
--
P/B
-13.03
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.79%
Amplitude
3.65%
Avg Price
41.166
Lot Size
1
Float Cap
2.65B
Bid/Ask %
33.33%
Historical High
78.720
Shs Float
64.45M
Volume Ratio
1.01
Historical Low
4.030
Dividend TTM
--
P/B
-13.03
Dividend LFY
--
Turnover Ratio
0.79%
Amplitude
3.65%
Avg Price
41.166
Lot Size
1
Price Forecast

News

Comment

No Data

Company Overview More
PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The firm's portfolio includes Translarna, Emflaza, Tegsedi, Waylivra, and Evrysdi. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.
CEO: Dr. Stuart W. Peltz, PhD
Market: NASDAQ
Listing Date: 06/20/2013
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist